A new technique improves the 'in vitro' pregnancy rate

A study, that has won the first prize of the Spanish society of fertility research, has demonstrated the effectiveness of a new therapy in improving pregnancy rates in treatments of fertilization in vitro in women with a low response to ovarian stimulation. Currently one of the main problems which are specialists in assisted reproduction - whose incidence is estimated between 10 and 25% of the cases - is that many of the patients have a response to low ovarian stimulation, and this reduces the possibilities that get a pregnancy compared to those that respond adequately to this treatment.
Due to the problem posed by the low response to ovarian stimulation, researchers have studied ways to increase the pregnancy rate but, for the moment, there is no consensus on what could be an optimal protocol to help these patients to achieve pregnancy.
The new trial is based on preparing antral follicles before fertilization vitro to improve follicular growth, and thus increase the number of oocytes collected and quality
The new trial, called Follprim, which has been directed by the research group of reproductive medicine of the Institute of research health the faith (ISS faith), is based on preparing antral follicles before fertilization vitro seeking thereby improve follicular growth, and thus increase the number of oocytes collected and its quality in the case of women with low response.
Dr. Marzal Alicia, one of the main researchers, explained that his test results have confirmed that this technique is effective and that have managed to increase pregnancy rates in patients treated with testosterone.

Article contributed for educational purposes